TPC
STTK icon

Takeda Pharmaceutical Company’s Shattuck Labs STTK Stock Holding History

Takeda Pharmaceutical Company’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.23M Hold
515,619
– – 7.53% 4
2025
Q2 		$408K Hold
515,619
– – 2.09% 6
2025
Q1 		$490K Hold
515,619
– – 3.02% 6
2024
Q4 		$624K Hold
515,619
– – 2.35% 5
2024
Q3 		$1.8M Hold
515,619
– – 4.74% 4
2024
Q2 		$1.99M Sell
515,619
-985,442
-66% -$8.01M 0.86% 7
2024
Q1 		$13.4M Sell
1,501,061
-589,797
-28% -$5.4M 4.64% 5
2023
Q4 		$14.9M Buy
+2,090,858
New +$5.7M 4.55% 5

Other funds holding STTK

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CEI
Clark Estates Inc New York $434M AUM 15% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Takeda Pharmaceutical Company's STTK Position: Q3 2025 in Review

Takeda Pharmaceutical Company held its Shattuck Labs (STTK) position steady in Q3 2025 at 515,619 shares worth $1.23M. The position accounts for 7.53% of the portfolio, ranked #4.

Takeda Pharmaceutical Company first reported a position in STTK in Q4 2023 and has held it in 8 quarters since. The position peaked at $14.9M in Q4 2023. 56 funds tracked by Wall St. Rank hold STTK as of Q3 2025.

  • Takeda Pharmaceutical Company held 515,619 shares of Shattuck Labs worth $1.23M as of Q3 2025.
  • Takeda Pharmaceutical Company left its Shattuck Labs share count unchanged in Q3 2025.
  • Shattuck Labs made up 7.53% of Takeda Pharmaceutical Company's portfolio in Q3 2025, its #4 holding.
  • Takeda Pharmaceutical Company first reported a position in Shattuck Labs in Q4 2023 and has held it in 8 quarters since.
  • Takeda Pharmaceutical Company's Shattuck Labs position peaked at $14.9M in Q4 2023.
  • 56 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2025.

Based on Takeda Pharmaceutical Company's 13F filing for Q3 2025, filed 13 Nov 2025.